In 2022, Keith J. Kendall earned $2.50M in total compensation at Aquestive Therapeutics, Inc., primarily from $254.04K salary. Led Aquestive Therapeutics, Inc. as CEO for 7 years.
Compensation History
Annual executive compensation data for Keith J. Kendall, including salary, bonuses, and stock awards.
Year
2022
Total Compensation
$2.50M
Salary
$254.04K
Bonus
$0.00
Other
$2.24M
Salary
$254.04KBoard Justification
N/A
Bonus
$0.00Board Justification
N/A
Other Compensation
$2.24MBoard Justification
Includes 401(k) Company match of $15,242, Disability insurance premiums of $16,426, Life insurance premiums of $64,464, and Severance of $2,146,463.
Restricted Stock
Board Justification
N/A
Performance Metrics
N/A
Keith J. Kendall
Ex-CEO of Aquestive Therapeutics, Inc.
Education
B.S. from St. John’s University and an M.B.A from Pace University.
Field of Expertise
Business & Management
Sector of Economy
Healthcare
Born
January 1, 1958 - 67 years ago
CEO of Aquestive Therapeutics, Inc. for
7 years 8 months (Nov 2014 - Jul 2022)
Previous Experience
President and Chief Operating Officer at Aquestive Therapeutics, Inc.
Other Aquestive Therapeutics, Inc. CEOs
Holdings
Track Keith J. Kendall's stock holdings and portfolio value over time.
Insider Trading
Keith J. Kendall's recent stock transactions, purchases, and sales filed with the SEC.
No insider trades found for this CEO.
Rivals
Compare Keith J. Kendall with competitor CEOs and industry peers.